NASDAQ
30.06.25 | 21:43
21,990 US-Dollar
0,00 % 0,000
- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| ELECTROMED Aktie jetzt für 0€ handeln | |||||
| 09.06. | Electromed, Inc. to Present at the Investor Summit Virtual on June 10, 2025 | 138 | ACCESS Newswire | NEW PRAGUE, MN / ACCESS Newswire / June 9, 2025 / Electromed, Inc. announced that Jim Cunniff, President and Chief Executive Officer, will be presenting at the Investor Summit Virtual taking place on... ► Artikel lesen | |
| 27.05. | Electromed wird in die Russell 2000 und 3000 Indizes aufgenommen | 3 | Investing.com Deutsch | ||
| 14.05. | Electromed signals ongoing sales force expansion and highlights $5M share repurchase amid double-digit revenue growth | 1 | Seeking Alpha | ||
| 13.05. | Electromed Inc. Bottom Line Advances In Q3 | - | RTTNews | ||
| 13.05. | Electromed GAAP EPS of $0.21 beats by $0.01, revenue of $15.7M misses by $0.05M | 1 | Seeking Alpha | ||
| 13.05. | Electromed, Inc. - 10-Q, Quarterly Report | 1 | SEC Filings | ||
| 13.05. | Electromed, Inc. - 8-K, Current Report | 1 | SEC Filings | ||
| 03.04. | Electromed, Inc. to Present at the LD Micro Invitational XV | 266 | Newsfile | New Prague, Minnesota--(Newsfile Corp. - April 3, 2025) - Electromed, Inc. (NYSE American: ELMD) announced today that it will be participating in the 15th Annual LD Micro Invitational at the Westin... ► Artikel lesen | |
| 10.03. | Electromed Announces Share Repurchase Authorization | 1 | RTTNews | ||
| 10.03. | Electromed plant Aktienrückkauf im Wert von 5 Millionen US-Dollar | 1 | Investing.com Deutsch | ||
| 10.03. | Electromed authorizes up to $5 million share buyback program | 2 | Seeking Alpha | ||
| 10.03. | Electromed, Inc. - 8-K, Current Report | 2 | SEC Filings | ||
| 20.02. | Electromed is a new Buy at B. Riley; Buyout potential cited | 3 | Seeking Alpha | ||
| 20.02. | B.Riley sets $38 target on Electromed stock, starts with Buy | 3 | Investing.com | ||
| 12.02. | Electromed targets double-digit growth in FY2025 with SmartVest expansion and CRM upgrades | 1 | Seeking Alpha | ||
| 11.02. | Electromed GAAP EPS of $0.22 beats by $0.04, revenue of $16.3M beats by $1M | 1 | Seeking Alpha | ||
| 11.02. | Electromed, Inc. Announces Record Financial Performance in Fiscal 2025 Second Quarter | 643 | Business Wire | NEW PRAGUE, Minn.--(BUSINESS WIRE)--Electromed, Inc. ("Electromed" or the "Company") (NYSE American: ELMD), a leader in innovative airway clearance technologies, today announced financial results... ► Artikel lesen | |
| 11.02. | Electromed, Inc. - 10-Q, Quarterly Report | - | SEC Filings | ||
| 11.02. | Electromed, Inc. - 8-K, Current Report | - | SEC Filings | ||
| 28.01. | Electromed-Aktie erreicht Allzeithoch von 35,16 US-Dollar | - | Investing.com Deutsch |
1 2 Weiter >>
27 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| SIEMENS HEALTHINEERS | 46,700 | -0,76 % | Neue 5,68% Aktienanleihe auf Siemens Healthineers | Düsseldorf (www.anleihencheck.de) - Die HSBC Trinkaus & Burkhardt AG, Düsseldorf, bietet ab dem 24. Juni 2025 eine neue Aktienanleihe (ISIN DE000HT69A65/ WKN HT69A6) auf die Aktie der Siemens Healthineers... ► Artikel lesen | |
| NUTEX HEALTH | 124,49 | 0,00 % | Nutex Health added to Russell 3000 and Russell Microcap Index | ||
| FRESENIUS MEDICAL CARE | 48,580 | +0,31 % | Aktien im Fokus: Stimmungsumschwung bei Nvidia, Analysten zurückhaltend bei FMC, De.mem erwartet Boom bei Wasseraufbereitung | ||
| FRESENIUS | 42,410 | -0,68 % | Aktienmarkt: Fresenius SE & Co. KGaA-Aktie kann sich nicht behaupten (42,16 €) | Der Anteilsschein von Fresenius SE & Co. KGaA notiert am Mittwoch leichter. Die Aktie kostete zuletzt 42,16 Euro. Für Inhaber von Fresenius+Co KgaA ist der heutige Handelstag bisher nicht sonderlich... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 23,010 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports First Quarter 2025 Financial Results | Strong First Quarter Performance and Operating ExecutionEnters the State of ArizonaFull-Year 2025 Outlook Raised to Mid- to High End of Guidance Ranges for All Metrics with Attributed Lives Unchanged... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 23,590 | 0,00 % | TD Cowen Begins Coverage of BrightSpring Health Services (BTSG) Stock, Gives Buy | ||
| NEUROPACE | 11,140 | 0,00 % | NeuroPace, Inc.: NeuroPace Announces Strategic CFO Transition | Appoints Patrick F. Williams as Chief Financial Officer Williams Brings a Track Record of Leading Medical Device Public Companies as CFO Rebecca Kuhn Departing Company and Will Remain in Advisory... ► Artikel lesen | |
| LIFEMD | 13,620 | 0,00 % | Hims & Hers vs. LifeMD: Which Telehealth Stock Has More Upside? | ||
| GENEDX | 92,23 | 0,00 % | Expert Outlook: GeneDx Holdings Through The Eyes Of 4 Analysts | ||
| ALIGNMENT HEALTHCARE | 13,995 | 0,00 % | Alignment Healthcare Reports Strong First Quarter 2025 Results; Exceeds High-End of Expectations On 4 Critical KPIs; Raises Midpoint of 2025 Guidance; Announces CFO Transition | Delivers Q1 revenue of $926.9 million, up 47.5% year over year, and grows Medicare Advantage (MA) membership by 31.7% to approximately 217,500 membersExceeds high-end of Q1 guidance on membership... ► Artikel lesen | |
| PROGYNY | 21,995 | 0,00 % | Here's Why Progyny (PGNY) Rebounded in Q1 | ||
| PROCEPT BIOROBOTICS | 57,65 | 0,00 % | PROCEPT BioRobotics Reports Fourth Quarter and Full Year 2024 Results | SAN JOSE, Calif., Feb. 25, 2025 (GLOBE NEWSWIRE) -- PROCEPT BioRobotics Corporation (Nasdaq: PRCT) (the "Company"), a surgical robotics company focused on advancing patient care by developing transformative... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 56,00 | 0,00 % | UBS stuft CARL ZEISS MEDITEC AG auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat Carl Zeiss Meditec auf "Neutral" belassen. In Gesprächen mit Investoren in Europa habe er ein gestiegenes Interesse an Medizintechnikunternehmen... ► Artikel lesen | |
| OMADA HEALTH | 18,190 | 0,00 % | Morgan Stanley initiates Omada Health stock with Overweight rating on chronic care focus | ||
| RXSIGHT | 12,980 | 0,00 % | RxSight, Inc. Announces Preliminary First Quarter 2025 Revenue and Revised 2025 Guidance | ALISO VIEJO, Calif., April 02, 2025 (GLOBE NEWSWIRE) -- (NASDAQ: RXST) - RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following... ► Artikel lesen |
Das Unternehmen ELECTROMED INC kann der Branche Gesundheitswesen zugeordnet werden. Der aktuelle Kurs liegt bei 21,990 Euro und damit 0,00 % im Plus.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und .
Weitere Kennzahlen, Fundamentaldaten und Unternehmensinformationen zu ELECTROMED INC finden Sie auf Wallstreet Online.